Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAD21L1 encodes a meiosis-specific cohesin complex subunit of the α-kleisin family, highly expressed in reproductive tissues such as testis and ovary[2][4]. The protein localizes to chromosome axes during the leptotene and zygotene stages of meiosis and is critical for synapsis and separation of homologous chromosomes[1][2][6]. In vertebrates such as zebrafish and mice, loss of RAD21L1 impairs oogenesis, causing defects in chromosome synapsis and triggering checkpoint-mediated cell death, leading to poor gamete quality and reduced fertility, while spermatogenesis is less affected[1]. RAD21L1 is essential for meiotic chromosome structure and integrity, but it is not currently a direct clinical or pharmacological target[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double-strand-break repair protein RAD21-like 1 (RAD21L1).